SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001615219-21-000038
Filing Date
2021-04-27
Accepted
2021-04-27 16:07:24
Documents
5

Document Format Files

Seq Description Document Type Size
1 DEFA14A salarius-defa14a2021proxyc.htm DEFA14A 18897
2 image1a.jpg GRAPHIC 53044
3 image2a.jpg GRAPHIC 149698
4 image_01a.jpg GRAPHIC 2384
5 salarius-ntcxfinal_pagex41a.jpg GRAPHIC 31091
  Complete submission text file 0001615219-21-000038.txt   345496
Mailing Address 2450 HOLCOMBE BLVD SUITE J-608 HOUSTON TX 77021
Business Address 2450 HOLCOMBE BLVD SUITE J-608 HOUSTON TX 77021 346-772-0346
Salarius Pharmaceuticals, Inc. (Filer) CIK: 0001615219 (see all company filings)

IRS No.: 465087339 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-36812 | Film No.: 21858969
SIC: 2834 Pharmaceutical Preparations